DOCSLIB.ORG

Epigenetic Modifications in Vascular Disease and Regenerative Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Epigenetic Modifications in Vascular Disease and Regenerative Medicine Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München Epigenetic modifications in vascular disease and regenerative medicine Mihaela Culmes aus Racari, Rumänien 2012 Erklärung Diese Dissertation wurde im Sinne von § 7 der Promotionsordnung vom 28. November 2011 von Herrn PD Dr. Jaroslav Pelisek betreut und von Herrn Prof. Dr. Ernst Wagner von der Fakultät für Chemie und Pharmazie vertreten. Eidesstattliche Versicherung Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. München, 22.09.2012 . ......................... Mihaela Culmes Dissertation eingereicht am 22.09.2012 1. Gutachter: Prof. Dr. Ernst Wagner 2. Gutachter: PD Dr. Jaroslav Pelisek Mündliche Prüfung am 05.12.2012 From far away to us you came to improve your ken and knowledge it was your dream and inner aim to graduate and end the college foreign country, different manner the start wasn’t easy, not at all but still faithful under your banner you always followed your own call persistent and beyond the doubt you went on with lifted head in hope of fortune looking out high spirits around did you spread scientist with heart and soul all the time you have been challenging the others goal to see more beyond the scene always open, ready to aid to explain, improve the others never mind the price you paid as you’d help your own brothers So I esteemed to work with you and helped you to find your fate ‘cause you’re the one to have a clue. And now here you stand to pass the gate dedicated by J.P. I TABLE OF CONTENTS 1 INTRODUCTION 1 1.1 Epigenetics ................................................................................................................................ 1 1.1.1 DNA methylation and DNMTs ................................................................................................. 1 1.1.2 Hydroxymethylation, TET1 ...................................................................................................... 3 1.1.3 Histone modifications – methylation and acetylation .............................................................. 4 1.1.4 Histone methyltransferases and their role ............................................................................... 5 1.2 Epigenetic changes in vascular disease ................................................................................ 9 1.2.1 Atherosclerosis is the leading cause of stroke and heart attack ............................................. 9 1.2.2 Stages of atherosclerosis – histological classification ........................................................... 10 1.2.3 Role of epigenetics in vascular disease ................................................................................ 14 1.2.4 Aim of the study – epigenetic changes in vascular disease .................................................. 16 1.3 Epigenetic changes in regenerative medicine ..................................................................... 18 1.3.1 Reprogramming of mesenchymal stem cells (MSCs) through epigenetics .......................... 19 1.3.2 Epigenetic modifying drugs and cell reprogramming ............................................................ 20 1.3.2.1 5-azacytidine, inhibitor of global DNA methylation ........................................................ 21 1.3.2.2 BIX-01294, a small molecule able to inhibit the G9a methyltransferase ....................... 22 1.3.2.3 Valproic acid as a histone deacethylase inhibitor ......................................................... 24 1.3.3 Adipose tissue more than a fat storage ................................................................................. 24 1.3.4 Cellular components of adipose tissue and relevant CD markers expression pattern ......... 25 1.3.5 Source of mesenchymal stem cells and their differentiation potential .................................. 27 1.3.6 Regenerative medicine and vascular disease ....................................................................... 27 1.3.7 Biological grafts ..................................................................................................................... 28 1.3.8 Aim of the study - epigenetics in regenerative medicine ....................................................... 29 2 MATERIALS AND METHODS 31 2.1 Cell culture experiments ......................................................................................................... 31 2.1.1 Isolation of primary adipose derived mesenchymal stem cells (adMSCs) ............................ 31 2.1.2 Cell culture ............................................................................................................................. 33 2.1.2.1 Culture of adipose-derived mesenchymal stem cells .................................................... 33 2.1.2.2 Osteogenic differentiation .............................................................................................. 33 2.1.2.3 Adipogenic differentiation .............................................................................................. 33 2.1.2.4 Endothelial differentiation .............................................................................................. 34 2.1.2.5 Cell line used as positive control ................................................................................... 34 2.1.2.6 Cell propagation ............................................................................................................ 34 2.1.2.7 Cell counting .................................................................................................................. 35 TABLE OF CONTENTS II 2.1.3 Cell culture analysis ............................................................................................................... 36 2.1.3.1 Cytochemistry ................................................................................................................ 36 2.1.3.1.1 Von Kossa staining ................................................................................................... 36 2.1.3.1.2 Alkaline phosphatase staining .................................................................................. 37 2.1.3.1.3 Oil red O staining ...................................................................................................... 38 2.1.3.2 Assays ........................................................................................................................... 38 2.1.3.2.1 Viability assay ........................................................................................................... 38 2.1.3.2.2 Alkaline phosphatase activity assay ......................................................................... 39 2.1.3.2.3 Oil Red O quantification assay ................................................................................. 40 2.1.3.2.4 Sulphorodamine B – protein measurement .............................................................. 40 2.1.3.2.5 Ac-LDL uptake .......................................................................................................... 41 2.2 Immunohistochemistry ........................................................................................................... 41 2.2.1 LSAB method ........................................................................................................................ 41 2.2.2 APAAP method ...................................................................................................................... 42 2.3 Flow cytometry (FACS analysis) ............................................................................................ 43 2.4 Tissue sampling, processing, and analysis ......................................................................... 44 2.4.1 Study group, atherosclerotic plaque processing, and characterization ................................. 44 2.4.2 Decellularisation and recellularization ................................................................................... 45 2.4.3 Histochemistry ....................................................................................................................... 46 2.4.3.1 Haematoxylin – Eosin staining ...................................................................................... 46 2.4.3.2 Elastica van Giesson staining ....................................................................................... 46 2.4.4 Immunohistochemistry........................................................................................................... 47 2.4.5 Microscopy and digitalization ................................................................................................ 47 2.5 Gene expression analysis at mRNA level using PCR.......................................................... 48 2.5.1 RNA extraction from cells ...................................................................................................... 48 2.5.2 RNA extraction from FFPE tissue samples ........................................................................... 48 2.5.3 cDNA synthesis ..................................................................................................................... 48 2.5.4 SYBR Green-based real-time PCR ....................................................................................... 49 2.6 Epigenetic analysis of methylated DNA using PCR ............................................................ 52 2.6.1 DNA isolation from cells .......................................................................................................
Load more

Recommended publications
  • Histone Methylases As Novel Drug Targets. Focus on EZH2 Inhibition. Catherine BAUGE1,2,#, Céline BAZILLE 1,2,3, Nicolas GIRARD1
    Histone methylases as novel drug targets. Focus on EZH2 inhibition. Catherine BAUGE1,2,#, Céline BAZILLE1,2,3, Nicolas GIRARD1,2, Eva LHUISSIER1,2, Karim BOUMEDIENE1,2 1 Normandie Univ, France 2 UNICAEN, EA4652 MILPAT, Caen, France 3 Service d’Anatomie Pathologique, CHU, Caen, France # Correspondence and copy request: Catherine Baugé, [email protected], EA4652 MILPAT, UFR de médecine, Université de Caen Basse-Normandie, CS14032 Caen cedex 5, France; tel: +33 231068218; fax: +33 231068224 1 ABSTRACT Posttranslational modifications of histones (so-called epigenetic modifications) play a major role in transcriptional control and normal development, and are tightly regulated. Disruption of their control is a frequent event in disease. Particularly, the methylation of lysine 27 on histone H3 (H3K27), induced by the methylase Enhancer of Zeste homolog 2 (EZH2), emerges as a key control of gene expression, and a major regulator of cell physiology. The identification of driver mutations in EZH2 has already led to new prognostic and therapeutic advances, and new classes of potent and specific inhibitors for EZH2 show promising results in preclinical trials. This review examines roles of histone lysine methylases and demetylases in cells, and focuses on the recent knowledge and developments about EZH2. Key-terms: epigenetic, histone methylation, EZH2, cancerology, tumors, apoptosis, cell death, inhibitor, stem cells, H3K27 2 Histone modifications and histone code Epigenetic has been defined as inheritable changes in gene expression that occur without a change in DNA sequence. Key components of epigenetic processes are DNA methylation, histone modifications and variants, non-histone chromatin proteins, small interfering RNA (siRNA) and micro RNA (miRNA).
    [Show full text]
  • Ordered Changes in Histone Modifications at the Core of The
    Ordered changes in histone modifications at the core of the Arabidopsis circadian clock Jordi Malapeira1, Lucie Crhak Khaitova1, and Paloma Mas2 Molecular Genetics Department, Center for Research in Agricultural Genomics (CRAG), Consortium Consejo Superior de Investigaciones Científicas–Institut de Recerca i Tecnologia Agroalimentaries–Universitat Autònoma de Barcelona–Universitat de Barcelona, Campus Universitat Autònoma de Barcelona, 08193 Barcelona, Spain Edited* by Steve A. Kay, University of California at San Diego, La Jolla, CA, and approved November 15, 2012 (received for review October 1, 2012) Circadian clock function in Arabidopsis thaliana relies on a com- RELATED 3 (SDG2/ATXR3) was proposed to play a major role plex network of reciprocal regulations among oscillator components. in H3K4 trimethylation (H3K4me3) in Arabidopsis (16, 17). Loss Here, we demonstrate that chromatin remodeling is a prevalent of SDG2/ATXR3 function results in pleiotropic phenotypes, as well regulatory mechanism at the core of the clock. The peak-to-trough as a global decrease of H3K4me3 accumulation and altered ex- circadian oscillation is paralleled by the sequential accumulation of pression of a large number of genes. H3 acetylation (H3K56ac, K9ac), H3K4 trimethylation (H3K4me3), A precise regulation of gene expression is not only essential and H3K4me2. Inhibition of acetylation and H3K4me3 abolishes os- for plant responses to environmental stresses and developmental cillator gene expression, indicating that both marks are essential for transitions but also for proper function of the circadian clock. gene activation. Mechanistically, blocking H3K4me3 leads to in- The circadian clockwork allows plants to anticipate environ- creased clock-repressor binding, suggesting that H3K4me3 functions mental changes and adapt their activity to the most appropriate as a transition mark modulating the progression from activation to time of day (18).
    [Show full text]
  • Epigenetic Regulation of Development by Histone Lysine Methylation
    Heredity (2010) 105, 24–37 & 2010 Macmillan Publishers Limited All rights reserved 0018-067X/10 $32.00 www.nature.com/hdy REVIEW Epigenetic regulation of development by histone lysine methylation S Dambacher1, M Hahn1 and G Schotta Munich Center for Integrated Protein Science (CiPSM) and Adolf-Butenandt-Institute, Ludwig-Maximilians-University, Munich, Germany Epigenetic mechanisms contribute to the establishment and (HMTases) and specific binding factors for most methylated maintenance of cell-type-specific gene expression patterns. lysine positions has provided a novel insight into the mechanisms In this review, we focus on the functions of histone lysine of epigenetic gene regulation. In addition, analyses of HMTase methylation in the context of epigenetic gene regulation during knockout mice show that histone lysine methylation has developmental transitions. Over the past few years, analysis of important functions for normal development. In this study, we histone lysine methylation in active and repressive nuclear review mechanisms of gene activation and repression by histone compartments and, more recently, genome-wide profiling of lysine methylation and discuss them in the context of the histone lysine methylation in different cell types have revealed developmental roles of HMTases. correlations between particular modifications and the transcrip- Heredity (2010) 105, 24–37; doi:10.1038/hdy.2010.49; tional status of genes. Identification of histone methyltransferases published online 5 May 2010 Keywords: epigenetics; histone lysine methylation; heterochromatin; mouse development Introduction Activation and repression are facilitated by Development is accomplished by spatial and temporal histone lysine methylation regulation of gene expression patterns. The identity of Major methylation sites on histones H3 and H4 are each cell type is maintained and passed on to daughter located in the tail (H3K4, H3K9, H3K27, H3K36 and cells by mechanisms that do not alter the DNA sequence H4K20) and the nucleosome core region (H3K79).
    [Show full text]
  • Changes in Histone Methylation and Acetylation During Microspore Reprogramming to Embryogenesis Occur Concomitantly with Bnhkmt
    View metadata, citation and similarbroughtCORE papers to you at by core.ac.uk provided by Digital.CSIC Changes in histone methylation and acetylation during microspore reprogramming to embryogenesis occur concomitantly with BnHKMT and BnHAT expression and are associated to cell totipotency, proliferation and differentiation in Brassica napus Héctor Rodríguez-Sanz1, Jordi Moreno-Romero2, María-Teresa Solís1, Claudia Köhler2, María C. Risueño1, Pilar S. Testillano1,* 1Pollen Biotechnology of Crop Plants Group. Centro de Investigaciones Biológicas (CIB) CSIC. Ramiro de Maeztu 9, 28040 Madrid, Spain. 2Department of Plant Biology, Uppsala BioCenter, Swedish University of Agricultural Sciences and Linnean Centre of Plant Biology, PO Box 7080, SE-750-07 Uppsala, Sweden. *Corresponding author Phone: +34-918373112 Fax: +34-915360432 E-mail: [email protected] 1 Abstract In response to stress treatments, microspores can be reprogrammed to become totipotent cells that follow an embryogenic pathway producing haploid and double-haploid embryos, which are important biotechnological tools in plant breeding. Recent studies have revealed the involvement of DNA methylation in regulating this process, but no information is available on the role of histone modifications in microspore embryogenesis. Histone modifications are major epigenetic marks controlling gene expression during plant development and in response to environment. Lysine methylation of histones, accomplished by histone lysine methyltransferases (HKMTs), can occur on different lysine residues, with histone H3K9 methylation being mainly associated with transcriptionally silenced regions. In contrast, histone H3 and H4 acetylation is carried out by histone acetyltransferases (HATs) and is associated with actively transcribed genes. In this work we analyze three different histone epigenetic marks: dimethylation of H3K9 (H3K9me2) and acetylation of H3 and H4 (H3Ac and H4Ac) during microspore embryogenesis in Brassica napus, by Western blot and immunofluorescence assays.
    [Show full text]
  • Regulation of Histone Methylation by Automethylation of PRC2
    Downloaded from genesdev.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Regulation of histone methylation by automethylation of PRC2 Xueyin Wang,1,2,3,5 Yicheng Long,1,2,5 Richard D. Paucek,1,2,4 Anne R. Gooding,1,2 Thomas Lee,2 Rachel M. Burdorf,1,2 and Thomas R. Cech1,2 1Howard Hughes Medical Institute, University of Colorado at Boulder, Boulder, Colorado 80309, USA; 2Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado at Boulder, Boulder, Colorado, 80309 USA Polycomb-repressive complex 2 (PRC2) is a histone methyltransferase that is critical for regulating transcriptional repression in mammals. Its catalytic subunit, EZH2, is responsible for the trimethylation of H3K27 and also undergoes automethylation. Using mass spectrometry analysis of recombinant human PRC2, we identified three methylated lysine residues (K510, K514, and K515) on a disordered but highly conserved loop of EZH2. Methylation of these lysines increases PRC2 histone methyltransferase activity, whereas their mutation decreases activity in vitro. De novo histone methylation in an EZH2 knockout cell line is greatly impeded by mutation of the automethylation lysines. EZH2 automethylation occurs intramolecularly (in cis) by methylation of a pseudosubstrate sequence on a flexible loop. This posttranslational modification and cis regulation of PRC2 are analogous to the activation of many protein kinases by autophosphorylation. We propose that EZH2 automethylation allows PRC2 to modulate its histone methyltransferase activity by sensing histone H3 tails, SAM concentration, and perhaps other effectors. [Keywords: CRISPR; epigenetics; H3K27me3; lysine methylation; pseudosubstrate] Supplemental material is available for this article. Received May 15, 2019; revised version accepted July 30, 2019.
    [Show full text]
  • The Polycomb Ezh2 Methyltransferase Regulates Muscle Gene Expression and Skeletal Muscle Differentiation
    Downloaded from genesdev.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation Giuseppina Caretti,1 Monica Di Padova,1 Bruce Micales,2 Gary E. Lyons,2 and Vittorio Sartorelli1,3 1Muscle Gene Expression Group, Laboratory of Muscle Biology, NIAMS, National Institutes of Health, Bethesda, Maryland 20892, USA; 2Department of Anatomy, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA The Ezh2 protein endows the Polycomb PRC2 and PRC3 complexes with histone lysine methyltransferase (HKMT) activity that is associated with transcriptional repression. We report that Ezh2 expression was developmentally regulated in the myotome compartment of mouse somites and that its down-regulation coincided with activation of muscle gene expression and differentiation of satellite-cell-derived myoblasts. Increased Ezh2 expression inhibited muscle differentiation, and this property was conferred by its SET domain, required for the HKMT activity. In undifferentiated myoblasts, endogenous Ezh2 was associated with the transcriptional regulator YY1. Both Ezh2 and YY1 were detected, with the deacetylase HDAC1, at genomic regions of silent muscle-specific genes. Their presence correlated with methylation of K27 of histone H3. YY1 was required for Ezh2 binding because RNA interference of YY1 abrogated chromatin recruitment of Ezh2 and prevented H3-K27 methylation. Upon gene activation, Ezh2, HDAC1, and YY1 dissociated from muscle loci, H3-K27 became hypomethylated and MyoD and SRF were recruited to the chromatin. These findings suggest the existence of a two-step activation mechanism whereby removal of H3-K27 methylation, conferred by an active Ezh2-containing protein complex, followed by recruitment of positive transcriptional regulators at discrete genomic loci are required to promote muscle gene expression and cell differentiation.
    [Show full text]
  • New Insights Into the Role of Histone Changes in Aging
    International Journal of Molecular Sciences Review New Insights into the Role of Histone Changes in Aging Sun-Ju Yi and Kyunghwan Kim * Department of Biology, School of Biological Sciences, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Chungbuk, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-(43)-2612292 Received: 14 October 2020; Accepted: 2 November 2020; Published: 3 November 2020 Abstract: Aging is the progressive decline or loss of function at the cellular, tissue, and organismal levels that ultimately leads to death. A number of external and internal factors, including diet, exercise, metabolic dysfunction, genome instability, and epigenetic imbalance, affect the lifespan of an organism. These aging factors regulate transcriptome changes related to the aging process through chromatin remodeling. Many epigenetic regulators, such as histone modification, histone variants, and ATP-dependent chromatin remodeling factors, play roles in chromatin reorganization. The key to understanding the role of gene regulatory networks in aging lies in characterizing the epigenetic regulators responsible for reorganizing and potentiating particular chromatin structures. This review covers epigenetic studies on aging, discusses the impact of epigenetic modifications on gene expression, and provides future directions in this area. Keywords: aging; histone level; histone modification; histone variant; chromatin remodeling; epigenetics 1. Introduction An individual organism undergoes a series of developmental stages, including birth, growth, maturity, aging, and death. Aging is the gradual and continuous decline or loss of function at the cellular, tissue, and organismal levels with the passage of time. Aging is considered to begin in early adulthood, but is regarded as an integral part of life since other stages also affect the aging process [1].
    [Show full text]
  • The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis
    J Lipid Atheroscler. 2020 Sep;9(3):419-434 Journal of https://doi.org/10.12997/jla.2020.9.3.419 Lipid and pISSN 2287-2892·eISSN 2288-2561 Atherosclerosis Review The Key Role of DNA Methylation and Histone Acetylation in Epigenetics of Atherosclerosis Han-Teo Lee ,1,2,* Sanghyeon Oh ,1,2,* Du Hyun Ro ,1,2,3,* Hyerin Yoo ,1,2 Yoo-Wook Kwon 4,5 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science, Seoul National University, Seoul, Korea 2Interdisciplinary Program in Stem Cell Biology, Graduate School of Medicine, Seoul National University, Seoul, Korea 3Department of Orthopedic Surgery, Seoul National University Hospital, Seoul, Korea 4Strategic Center of Cell and Bio Therapy for Heart, Diabetes & Cancer, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea Received: May 8, 2020 5Department of Medicine, College of Medicine, Seoul National University, Seoul, Korea Revised: Sep 14, 2020 Accepted: Sep 15, 2020 Correspondence to ABSTRACT Yoo-Wook Kwon Biomedical Research Institute, Seoul National Atherosclerosis, which is the most common chronic disease of the coronary artery, constitutes University Hospital, 103 Daehak-ro, Jongno- a vascular pathology induced by inflammation and plaque accumulation within arterial vessel gu, Seoul 03080, Korea. E-mail: [email protected] walls. Both DNA methylation and histone modifications are epigenetic changes relevant for atherosclerosis. Recent studies have shown that the DNA methylation and histone *Han-Teo Lee, Sanghyeon Oh and Du Hyun Ro modification systems are closely interrelated and mechanically dependent on each other. contributed equally to this work. Herein, we explore the functional linkage between these systems, with a particular emphasis Copyright © 2020 The Korean Society of Lipid on several recent findings suggesting that histone acetylation can help in targeting DNA and Atherosclerosis.
    [Show full text]
  • NIH Public Access Author Manuscript J Mol Biol
    NIH Public Access Author Manuscript J Mol Biol. Author manuscript; available in PMC 2012 May 27. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Mol Biol. 2011 May 27; 409(1): 36±46. doi:10.1016/j.jmb.2011.01.040. OPERating ON chromatin, a colorful language where context matters Kathryn E. Gardner1, C. David Allis2, and Brian D. Strahl1,* 1 Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA 2 Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY 10065, USA Abstract Histones, the fundamental packaging elements of eukaryotic DNA, are highly decorated with a diverse set of post-translational modifications (PTMs) that are recognized to govern the structure and function of chromatin. Ten years ago, we put forward the histone code hypothesis, which provided a model to explain how single and/or combinatorial PTMs on histones regulate the diverse activities associated with chromatin (e.g. gene transcription). At that time, there was a limited understanding of both the number of PTMs that occur on histones as well as the proteins that place, remove and interpret them. Since the conception of this hypothesis, the field has witnessed an unprecedented advance in our understanding of the enzymes that contribute to the establishment of histone PTMs, as well as the diverse effector proteins that bind them. While debate continues as to whether histone PTMs truly constitute a strict “code”, it is becoming clear that PTMs on histone proteins function in elaborate combinations to regulate the many activities associated with chromatin.
    [Show full text]
  • Histone Modifications: Now Summoning Sumoylation
    Histone modifications: Now summoning sumoylation Dafna Nathan, David E. Sterner, and Shelley L. Berger* Gene Expression and Regulation Program, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104 istones can be modified in Table 1. Transcription-related modifications of lysine residues in histone proteins many ways to affect gene ex- Primary pression, including acetyla- ͞ Histone Modifying transcriptional Nature of tion deacetylation (1), phos- modification enzymes Demodifying enzymes effect modification Hphorylation (2), methylation (3), and ubiquitylation (4). Now, in this issue of Acetylation HATs HDACs Activation Dynamic PNAS, Shiio and Eisenman (5) report Methylation HMTs ??? Activation͞repression Static that sumoylation is yet another histone Ubiquitylation Rad6* Ubiquitin proteases (UBPs) Activation Dynamic modification, and, interestingly, it may Sumoylation UBC9* ULP-related proteases† Repression Dynamic regulate transcriptional repression. Al- *Although other enzymes are involved in sumoylation and ubiquitylation, UBC9 (yeast through human) though there may appear to be a bewil- is the only known E2 SUMO-conjugating enzyme, and yeast Rad6 is the ubiquitin E2 known to monou- dering array of histone modifications biquitylate histones in vivo. involved with gene regulation, there †Although histone desumoylation has not yet been characterized, studies with other sumoylated sub- could be a fairly simple paradigm under- strates demonstrate deconjugation by ULP proteases. lying them. Eukaryotic DNA is packaged within the nucleus through its association with his- can, depending on context, contribute a SUMO to its substrate, to the reporter. tone proteins (H2A, H2B, H3, and H4), ‘‘permanent’’ mark of either open, ac- Moreover, the targeted UBC9 results in forming the fundamental repeating unit of tive euchromatin or closed, repressed reduced levels of promoter-associated chromatin, the nucleosome.
    [Show full text]
  • Spreading and Epigenetic Inheritance of Heterochromatin Require a Critical Density of Histone H3 Lysine 9 Tri-Methylation
    Spreading and epigenetic inheritance of heterochromatin require a critical density of histone H3 lysine 9 tri-methylation Amber R. Cutter DiPiazzaa, Nitika Tanejaa,1, Jothy Dhakshnamoorthya, David Wheelera, Sahana Hollaa, and Shiv I. S. Grewala,2 aLaboratory of Biochemistry and Molecular Biology, National Cancer Institute, NIH, Bethesda, MD 20892 Edited by Steven E. Jacobsen, University of California, Los Angeles, CA, and approved April 20, 2021 (received for review January 12, 2021) Heterochromatin assembly requires methylation of histone H3 domains coat pericentromeric, subtelomeric, and the silent mating- lysine 9 (H3K9me) and serves as a paradigm for understanding the type (mat) regions (9–12). Heterochromatin assembly is a multistep importance of histone modifications in epigenetic genome control. process that includes nucleation and spreading. The de novo nu- Heterochromatin is nucleated at specific genomic sites and spreads cleation of heterochromatin occurs at specific sites, such as repeat across extended chromosomal domains to promote gene silencing. elements within constitutive heterochromatin domains, from where Moreover, heterochromatic structures can be epigenetically inherited heterochromatin factors spread to surrounding sequences (13, 14). in a self-templating manner, which is critical for stable gene repres- RNAi machinery (13, 15), as well as factors involved in nuclear sion. The spreading and inheritance of heterochromatin are believed RNA processing and noncanonical RNA polymerase II termi- to be dependent on preexisting H3K9 tri-methylation (H3K9me3), nation (12, 16–19), nucleate heterochromatin by targeting the which is recognized by the histone methyltransferase Clr4/Suv39h multisubunit Clr4 methyltransferase complex (ClrC) (20) that is via its chromodomain, to promote further deposition of H3K9me. responsible for mono-, di-, and tri-methylation of histone H3K9 However, the process involving the coupling of the “read” and “write” (H3K9me1/2/3) (6, 21).
    [Show full text]
  • A Coactivator/ Corepressor/Epigenetic Code for Integrating Signal-Dependent Programs of Transcriptional Response
    Downloaded from genesdev.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Sensors and signals: a coactivator/ corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response Michael G. Rosenfeld,1,3 Victoria V. Lunyak,1,4 and Christopher K. Glass2,5 1Howard Hughes Medical Institute, Department of Molecular Medicine, 2Department of Cellular and Molecular Medicine, Department and School of Medicine, University of California, San Diego, La Jolla, California 92093, USA A decade of intensive investigation of coactivators and that these enzymatic activities are required not only for corepressors required for regulated actions of DNA-bind- modification of the integral components of the coregu- ing transcription factors has revealed a network of se- lator complexes but also have been shown to be involved quentially exchanged cofactor complexes that execute a in modifications of the components of the basic tran- series of enzymatic modifications required for regulated scriptional apparatus and chromatin at target gene pro- gene expression. These coregulator complexes possess moters. A second principle to emerge is that many regu- “sensing” activities required for interpretation of mul- lated transcription factors use a precise sequence of func- tiple signaling pathways. In this review, we examine re- tional actions by multiple coactivator complexes for cent progress in understanding the functional conse- mediating gene activation. These observations raise sev- quences of “molecular sensor” and “molecular adaptor” eral general questions, including: What are the biological actions of corepressor/coactivator complexes in integrat- and biochemical requirements and constraints that have ing signal-dependent programs of transcriptional re- driven evolution of the multitude of functionally re- sponses at the molecular level.
    [Show full text]